Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Bocidelpar

Generic Name: Bocidelpar

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₇F_₃N_₂O_₃

CAS Number: 2095128-20-2

Unique Ingredient Identifier: FKO8A7AD54

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Phase 1

Completed

Posted: 2021/11/11

Sponsor:Astellas Pharma Glob...

ID:NCT05117294

A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function

Phase 1

Completed

Posted: 2021/06/29

Sponsor:Astellas Pharma Glob...

ID:NCT04942964

A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction

Phase 1

Terminated

Posted: 2021/04/22

Sponsor:Astellas Pharma Glob...

ID:NCT04855201

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

Phase 2

Terminated

Posted: 2020/11/24

Sponsor:Astellas Pharma Inc

ID:NCT04641962

A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)

Phase 1

Terminated

Posted: 2019/12/04

Sponsor:Astellas Pharma Inc

ID:NCT04184882

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy